Predicting survival in ambulatory patients with severe heart failure on beta-blocker therapy

Lars H Lund; Keith D Aaronson; Donna M Mancini

doi:10.1016/j.amjcard.2003.08.027

Predicting survival in ambulatory patients with severe heart failure on beta-blocker therapy

Am J Cardiol. 2003 Dec 1;92(11):1350-4. doi: 10.1016/j.amjcard.2003.08.027.

Authors

Lars H Lund¹, Keith D Aaronson, Donna M Mancini

Affiliation

¹ Department of Medicine, Columbia University, New York, New York, USA.

PMID: 14636921
DOI: 10.1016/j.amjcard.2003.08.027

Abstract

Peak VO(2) and the Heart Failure Survival Score are 2 clinical parameters used to risk stratify patients with heart failure and time listing for cardiac transplantation. The efficacy of these prognostic variables in patients receiving beta-blocker therapy was evaluated.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Adrenergic beta-Antagonists / therapeutic use*
Adult
Aged
Female
Heart Failure / drug therapy*
Heart Transplantation
Humans
Male
Middle Aged
Oxygen Consumption / physiology
Predictive Value of Tests
Prognosis
Risk Assessment
Survival Analysis

Substances

Adrenergic beta-Antagonists